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Molecular epidemiology is enabling BUSM researchers to study, with a 
view toward creating more effective vaccines, genetic variation in 
populations of bacteria that cause serious infections of the urinary tract. 
See story on page 3. 
Richard M. Niles, Ph.D., right, and graduate student John Stoddard discuss the anti-tumor 
effects of vitamin A. (Photo by fJlichael McGovern) 
Research on myocardial relaxation 
leading to new therapies for heart failure 
Noninvasive cardiac diagnostic techni-
ques brought into widespread use only 
in the last 10 years have led to the 
reassessment of a previously unap-
preciated kind of heart disease, ac-
cording to Carl S. Apstein, M.D., a 
professor of medicine at Boston 
University School of Medicine and 
director of the School's Cardiac 
Muscle Research Laboratory (CMRL). 
As many as 30 percent of patients 
with heart failure symptoms, it now is 
known, experience shortness of breath 
and develop pulmonary congestion as 
a result of an Inability of the heart 
muscle to relax completely between 
beats (during diastole), rather than 
from an impairment of the heart's 
ability to contract and push the blood 
through the arteries (during systole). 
Abnormalities of myocardial relaxation 
mean pressures inside the ventricles 
remain too high during diastole, impair-
ing blood flow into the chambers and 
raising the capillary pressures in the 
lungs, resulting in shortness of breath. 
Apstein, who also is chief of cardiol-
ogy at Boston City Hospital, and his 
co-workers have been investigating 
mechanisms of myocardial relaxation 
in normal and abnormal heart muscle, 
continued on page 5 
BUSM Studies 
uncover links 
between vitamin A 
and cancer 
While the debate continues over the 
protective effects of certain foods 
against cancer, work is going forward 
in the laboratory of Richard M. Niles, 
Ph.D., a professor of biochemistry at 
Boston University School of Medicine, 
on the anti-tumor properties of one im-
portant dietary requirement—vitamin A. 
Niles and his colleagues have a 
number of experiments under way that 
are aimed at revealing how at the 
molecular level retinoic acid—one of 
the forms vitamin A is converted to in 
the body—prompts a tumor's undif-
ferentiated ceils to return to their nor-
mal, differentiated state. 
Vitamin A is well understood in 
terms of the role it plays in vision and 
the prevention of night blindness. But 
it also is important in two other areas. 
One is during fetal development, 
where a critical concentration of 
vitamin A is required for normal growth 
and development; too much or too little 
results in malformations. 
"The second area in which vitamin 
A is needed is in maintaining epithelial 
tissues in their normal state of differen-
tiation," explained Niles. (Epithelial 
ceils line body cavities and carry out 
most of the functions of various or-
gans, such as the secretion of mucus.) 
"in other words, vitamin A keeps 
epithelial ceils In their proper state so 
that they can do their job." 
continued on page 2 
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Vitamin A... 
continued from page 1 
Vitamin A appears to act against 
the two main haiimarks of cancer— 
rapid ceii growth and undifferentiated 
character. In most cancer cells, 
vitamin A haits growth and in many 
types of tumors, either by itself or in 
conjunction with another chemicai, for-
ces the undifferentiated ceils to take 
on their normal properties. To inves-
tigate this connection, Niles is looking 
at three model systems in culture; two 
are derived from tumor ceils and one 
from normal ceils: 
Using a melanoma ceii line, Niles is 
investigating how retinoic acid inhibits 
ceii growth and changes the activity of 
two key regulatory enzymes involved 
in growth and differentiation. Ceils 
treated with retinoic acid have more of 
these enzymes in them than untreated 
ceils and Niles is conducting experi-
ments to see how they carry out the 
work of inhibiting tumor growth. 
In connection with these studies, 
Niles is working with Judith Gampisi, 
Ph.D., an assistant professor of 
biochemistry, to understand how 
retinoic acid supresses the expression 
of the proto-oncogene c-myc. Ceils 
that are growing rapidly, such as 
melanoma ceils, express c-myc at a 
high level. Upon exposure to retinoic 
acid, the expression of the c-myc gene 
is drastically inhibited—but the question 
remains, why? Does expression 
decrease because growth is slowed, 
or is the decrease of c-myc expression 
responsible for the slowed growth? 
in a second set of experiments, 
Niles is using a teratocarcinoma ceii 
line derived from mouse testes to un-
derstand how retinoic acid works with 
another compound to transform malig-
nant germ ceils into non-malignant 
ceils, it has been shown that these 
non-malignant ceils do not cause 
tumors when Injected back Into the 
mouse. Because teratocarcinomas 
are derived from germ cells, they have 
the potential to differentiate Into any 
tissue of the body. Tumors of this 
type tend to spontaneously differen-
tiate so that a single tumor might con-
tain eye tissue, kidney tissue and hair 
ceils, for example, in this system, 
cyclic adenosine monophosphate 
(cAMP) is needed along with retinoic 
acid to induce normal differentiation. 
"We used to think that retinoic acid 
by itself could drive the differentiation 
process, but recent re-evaiuation has 
indicated that retinoic acid alters the 
ceils in some way so that they be-
come receptive to cAMP and that it is 
actually cAMP that drives the differen-
tiation most of the way," said Niles. 
Niles is using this ceii line to study 
how this differentiation process occurs 
at a molecular level, and why the dif-
ferentiated ceils lose their malignancy. 
The third system under investiga-
tion is a normal ceii line derived from 
the respiratory tract of a hamster. 
When airway epithelial cells (the 
ciliated and mucus-producing cells 
that line the entire respiratory tract ex-
cept for the terminal air sacs in the 
lungs) are taken from the animal and 
cultured, they tend to lose their dif-
ferentiated function (their ciiiated or 
mucus-secreting characteristics) and 
grow rapidly until they fill the dish. At 
that point, the cells re-acquire their 
normal functions. When epithelial 
ceils are grown with the minimum re-
quirement of retinoic acid and then 
given supplements at different stages 
of their growth, Niles has found that 
the differentiation process can be af-
fected, it appears that if retinoic acid 
is added at a time when the ceils are 
rapidly growing (without differentia-
tion), differentiation can largely be 
preserved. 
"This is important," said Niles, "be-
cause if you put animals on a vitamin 
A-deficient diet, you can observe that 
the cells of the airway flatten out and 
lose their differentiated properties, 
which is characteristic of precan-
cerous change. You can remove 
these cells from the animal and cui-
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Top pfioto sfiows uncontrolled growtfi of 
F9 teratocarcinoma cells. In bottom ptioto, 
cells treated witfi retinoic acid and cyclic 
AMP differentiate and become non-car-
cinogenic. (Pfiotos courtesy of Ricfiard M. 
Niles, Ph.D.) 
ture them with vitamin A and restore 
their normal shape and function." 
In addition to these experiments, 
Niles is developing a model to study 
carcinogenesis in normal epitheiiai 
ceils. "About 75 percent of human 
cancers are derived from epitheiiai 
ceils, including cancers of the breast, 
colon, prostate and lung," he said. 
Niles intends to take normal 
epitheiiai ceils and introduce cancer-
causing genes into them, in this way 
he will be able to determine, first of ail, 
which of a battery of known onco-
genes will transform the normal ceils 
into tumor ceils, if he can establish 
this, he then can determine if retinoic 
acid can prevent or ameliorate this 
transformation. 
Research on how retinoic acid 
produces its anti-tumor effects 
received a boost recently with the dis-
covery of a new class of retinoic acid 
binding protein with a DNA-binding 
region. "The thinking now is that 
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Molecular epidemiology yields insights 
into prevention of bacteriai infection 
these proteins reside in the nucleus 
and that binding proteins in the cyto-
plasm act as shuttles to take retinoic 
acid from the ceii membrane to the 
nucleus. At the nucleus retinoic acid 
is received by the "new" protein and 
bound to specific gene sites where it 
turns off or on a sequence of events 
to slow growth and induce differentia-
tion," explained Niles. 
In coiiaboration with Abdul Traish, 
Ph.D., an associate research profes-
sor of biochemistry, Niles is chemlcai-
iy synthesizing peptides that represent 
certain regions of the new receptor 
proteins and has made antibodies 
against them. Using the antibodies, 
Niles and Traish can determine 
^^^iother or not the proteins are local-
ized In the nucleus. Niles also has a 
mutant strain of melanoma ceii that is 
resistant to the action of retinoic acid 
and he will be looking to see if the 
mutation is in this new class of retinoic 
acid receptors. 
In addition to Campisi and Traish, 
Niles is assisted by master's degree 
candidate Betsy Winsiow, doctoral 
candidates Beth Goldstein and Anita 
Terpstra, and research technicians 
Barbara Loewy and Kate Brown. 
Niles' research is supported by the 
American Institute for Cancer 
Research; the National Cancer In-
stitute; the National Heart, Lung, and 
Blood Institute; and Aid for Cancer 
Research, a Boston-area nonprofit or-
ganization that raises funds for cancer 
research. 
—Caroline H. Lupfer 
Suggested Further Readings 
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Lower urinary tract infections are a 
recurring problem for about 10 per-
cent of premenopausal women, and 
upper urinary tract infections, though 
less common, are a potentially life-
threatening condition for those af-
fected. 
Richard Goldstein, Ph.D., a profes-
sor of molecular genetics and 
epidemiology in the Section of En-
vironmental Health of the School of 
Public Health at Boston University 
School of Medicine, has spent several 
years exploring how genetically con-
troiied variations in the molecular 
structure of bacterial surfaces in-
fluence the risk of getting such infec-
tions. Work he and his associates 
have done with the bacteria Es-
oheriohia co//suggest that variations 
in the makeup of its surfaces may sig-
nificantly influence the virulence of 
those strains that enter the urinary 
tract. 
E. CO//normally inhabit the intes-
tinal tract. The strains responsible for 
urinary tract infections—actually a 
very small proportion of ail E. ooli 
found in the gut—do not pose a health 
threat when in the intestines. If they 
enter the urinary tract, however, they 
can be a serious problem. 
Goldstein's group studied E. ooli 
isolated from various patients, includ-
ing young girls treated for urinary tract 
Infections at Massachusetts General 
Hospital, Cleveland Metropolitan 
Hospital and Boston City Hospital. 
They were surprised to find that ail the 
isolates differed in their chromosomal 
structures. 
According to Goldstein, this 
variability appears to result in part be-
cause certain key genes that deter-
mine a bacterium's virulence occupy 
widely different sites on the bacteriai 
chromosome, and because DNA se-
quences within these virulence genes 
Richard M. Goldstein, Ph.D., is studying 
the role of E. coll in urinary tract infections. 
(Photo by Bradford F. Herzog) 
show subtle but crucial degrees of 
variation, in addition, major portions 
of the total bacteriai chromosome ap-
pear to be in flux. The extent of such 
constant, though low-frequency, re-
arrangements is such that among E. 
CO//strains isolated from several 
hundred patients with the same type of 
infection, molecular epidemioiogic 
analyses indicated that no two patients 
yielded bacteria with an identical order 
of genes. 
Insights resulting from this new ap-
proach could have profound implica-
tions for efforts to create vaccines for 
urinary tract infections and other bac-
terial diseases, said Goldstein. 
A traditional vaccine stimulates 
responses only against the inherently 
limited number of surface molecules 
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found at a given moment on the or-
ganism against which it was made. In 
light of the enormous genetic 
variability the Goldstein group has 
found in E. co//—also the major cause 
of infant mortality due to diarrheal dis-
ease—it is clear that all the genetic-
mediated changes of surface com-
ponents need to be characterized to 
produce useful, multivalent vaccines. 
Using a technique that permits 
rapid searches for specific stretches 
of DNA, the researchers have begun 
correlating the expression of the dif-
ferent proteins responsible for binding 
the bacteria to human tissues—a pre-
requisite for infection—with switches 
in the basic structure of E. coli 
chromosomes. 
The E. co//strains that interest 
Goldstein's group are densely 
covered with fiber-like surface ap-
pendages called pill. These allow the 
bacteria to bind to the epitheiiai ceils 
lining the urinary tract. In the absence 
of such plii "adhesins," the bacteria 
cannot bind to the epitheiiai ceils, and 
thus cannot cause infection. 
Because the plii fibers are the 
major outer surface component of 
such bacteria, they are a major target 
of the human immune system. 
Genetic-mediated variation in the 
protein subunits of pill fibers enables 
piliated bacteria to circumvent im-
mune system assaults, explained 
Goldstein. 
According to the researcher, nine 
genes are required for the production 
of the pill fibers. Six or seven of these 
genes code for structural proteins, 
while the remainder play regulatory 
roles. 
Goldstein and his associates are 
particularly interested In the plii tips, 
which appear to effect binding to the 
host ceii. One intriguing feature of the 
proteins that make up the tip is that 
they seem to elicit only a minor im-
mune response by infected hosts. 
That characteristic, noted Goldstein, 
may be one of the factors that has im-
peded efforts to create vaccines 
Electron micrograph of E. coli shows 
numerous spiky pill that enable the bac-
teria to adhere to surface ceils of the 
urinary tract. Variations in the molecular 
structure of pill result in bacterial strains 
with widely varying binding capacities and 
ability to trigger immune responses. 
(Photo courtesy of Pichard Goldstein, 
Ph.D.) 
against piliated strains of E. coli. But 
the genetic-mediated variability in the 
makeup of these and other proteins 
also is an important factor. 
By analyzing the structure and loca-
tion of genes, the investigators have 
discovered a novel arrangement that 
may explain why some piliated E. ooli 
are more virulent than others of the 
same strain. 
The nine "basic" genes required for 
the assembly of a piius are located ad-
jacent to one another on the single, cir-
cular E. co//chromosome, in addition, 
however, the group has discovered 
variants of several of these genes in 
different parts of the chromosome. 
These variants, called "cassettes," 
can differ widely from one E. ooli iso-
late to another with respect to both 
chromosomal location and 
prevalence. The differences may 
even be found in bacteria isolated 
from patients affected by identical in-
fections. 
"Our hypothesis is that when one of 
these variant genes is located apart 
from that basic segment of nine 
genes, it won't be expressed," said 
Goldstein. 
On the other hand, if a similar gene 
cassette is occupying the key locale 
among the group of essential piius 
genes, that genetic cassette will be ex-
pressed, and its protein will form 
either the tip or the major portion of 
the piius. The reason, said Goldstein, 
is that the stretch of DNA that triggers 
expression of the various piius genes 
appears at only one or two distinct 
sites on the chromosome. 
Since most E. co//isolates were 
found to have several genes that 
potentially can encode tip or major 
subunit proteins, a change in gene 
location can lead to a dramatic 
change in the fibers' molecular struc-
ture, binding specificity and ability to 
trigger an immune response. 
Neither the switching of locations 
by variant genes nor the larger re-
arrangements of whole segments of • 
the bacteriai chromosome occur simul-
taneously within a given bacteriai 
population, instead, these changes 
appear as a random process over 
time. "Most changes, in fact, probably 
cause the bacterium affected to be-
come less rather than more 
pathogenic," said Goldstein. 
He noted, however, that his group 
Is not concerned with the occasional 
changes affecting a single bacterium. 
Their concern is the occurrence of 
such changes within large populations 
of bacteria, such as the estimated one 
billion E. co//occupying the average 
person's intestines. With such vast 
numbers, a change that seems rare 
becomes a fairly high-probability 
event. 
"Our studies of E. co//chromosome 
structures," said Goldstein, "suggest 
there is a low but steady-state flux 
that leads to genetic rearrangements 
as successive generations of the bac-
teria emerge." if there Is a "selective" 
pressure favoring a change—such as 
a human epitheiiai ceii to which the 
bacteria can adhere and colonize be-
cause of a genetic-mediated change 
of its outer surface—it appears that 
this particular pathogenic variation, 
which is just one of many possible, 
continued on page 6 
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Heart failure... 
continued from page 1 
and studying the effects of various 
drug therapies on relaxation. 
"Drug therapy for heart failure pre-
viously was aimed at improving the 
systolic (contractile) function of the 
heart without recognizing that this was 
not the fundamental abnormality in 
many patients," said Apstein. "In 
many patients with symptoms of heart 
failure, the heart ejects blood normally 
but the relaxation (diastolic) phase is 
abnormal." 
The Cardiac Muscle Research 
Laboratory group was the first to 
reproduce in isolated animal hearts 
the relaxation abnormalities that can 
occur in patients with stress-induced 
angina. They also showed that when 
the oxygen supply to isolated animal 
hearts is reduced as a result of 
oxygen deprivation (hypoxia) or 
reduced blood flow to the heart (is-
chemia)—mimicking conditions of 
heart disease or conditions that can 
occur during cardiac surgery, for ex-
ample— the isolated hearts 
developed the same Impairment of 
relaxation as seen in some patients 
with heart failure. The group also 
demonstrated that hearts from 
animals with high blood pressure and 
left ventricular hypertrophy (an enlar-
gement of the heart) had an exag-
gerated impairment of relaxation 
during conditions of oxygen depriva-
tion. 
"In other words, normal hearts 
show some impairment of relaxation 
under conditions of oxygen depriva-
tion, but nowhere near the extent of 
those from animals with hypertrophy 
resulting from high blood pressure. 
These findings fit the clinical picture 
that patients with myocardial relaxa-
tion problems frequently have a his-
tory of hypertension," explained 
Apstein. 
Apstein and co-workers in the Car-
diovascular Divisions at Beth Israel 
and Brigham & Women's hospitals in 
Boston, recently received a $3.8-mii-
iion progam project grant from the Na-
tional Institutes of Health to study 
diastolic relaxation in myocardial is-
chemia, hypertrophy and failure. 
Under this grant the researchers can 
use isolated hearts as models for 
patients with coronary disease or lung 
disease by altering the experimental 
conditions. For example, patients with 
coronary disease frequently have un-
stable angina—recurring periods of 
chest pain that result from a periodic 
reduction in blood supply to the heart 
due to coronary spasm or intermittent 
blood clot formation. By using isolated 
heart models, Apstein and his coi-
ieagues have shown that these 
episodes of ischemia greatly reduce 
the ability of the heart to relax normal-
ly. By turning coronary flow on and off 
in the isolated heart models, the de-
gree of relaxation impairment and the 
ability of different drugs to improve or 
worsen the condition can be measured. 
Apstein believes a major deter-
minant of myocardial relaxation is the 
level of calcium inside individual heart 
ceils, and that the reason different 
drugs have varying effects on heart 
muscle relaxation is due to the dif-
ferent ways in which they affect in-
traceilular calcium regulation. If there 
is an impairment in the cells' 
mechanism for getting rid of calcium, 
too much calcium builds up inside 
ceils and the heart muscle fibers can-
not relax normally. 
The investigators are studying beta 
blockers, calcium channel blockers, 
digitalis-type drugs, phosphodiesterase 
inhlbiters, and glucose and insulin—ail 
of which may affect intraceiiuiar cal-
cium regulation differently and, there-
fore, can be expected to have different 
effects on relaxation. So far they have 
observed that digitalis, which common-
ly Is used to treat heart failure resulting 
from poor muscle contractility, appears 
to make the relaxation process worse 
during periods of ischemia or hypoxia. 
"This emphasizes the importance 
Carl S. Apstein, M.D., describes researcii 
on myocardial relaxation and related drug 
therapies. (Photo by Bradford F. Herzog) 
of distinguishing in a given patient 
whether his heart failure is due to a 
systolic or a diastolic dysfunction. If 
not correctly characterized, the choice 
of drug treatment not only might not 
help the patient, it might hurt him," 
said Apstein. 
In contrast to digitalis-type com-
pounds, isoproterenol, one of a class 
of drugs known as beta andrenergic 
agonists that also are frequently used 
to treat patients with heart failure, did 
not appear to have a negative effect 
on relaxation when used in low doses, 
in addition, the group has studied the 
effect of high glucose and insulin on 
the relaxation abiiities of hearts from 
animals with hypertension and hyper-
trophy and found that, during periods 
of oxygen deprivation, the glucose 
and insulin improved the exaggerated 
impairment of relaxation in the hyper-
trophied hearts and made them be-
have like normal hearts. 
The studies of myocardial relaxa-
tion and infarct healing are being done 
in coiiaboration with W. Mark Vogel, 
Ph.D., associate director of the Car-
Research In Progress as 'poXl 
Boston University School of Medicine PAID 
Office of Publication Services Boston, Mass. 
80 East Concord St. Permit No. 53312 ^ 
Boston, MA 02118 ' 
diac Muscle Research Laboratory and 
an associate professor of pharmacol-
ogy. The program project grant re-
search on myocardial relaxation is 
being carried out in collaboration with 
William Grossman, M.D., chief of car-
diology at Beth Israel Hospital; 
Beverly H. Lorell, M.D., and Michael J. 
Cunningham, M.D., of Beth Israel 
Hospital; and Joanne S. Ingwall, 
Ph.D., and Frederick J. Schoen, M.D., 
Ph.D., of Brigham & Women's Hospi-
tal. Studies on hypertension and left 
ventricular hypertrophy are being 
done in coiiaboration with Aram 
Chobanian, M.D., director of the Car-
diovascular Institute at BUSM and 
dean of the School. 
—Caroline H. Lupfer 
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Bacterial infection... 
oontinued from page 4 
will be propagated during a given in-
fection. If this pathogenic variant of 
the organism confronts an immune 
system primed with a vaccine against 
this specific type, it will only be a mat-
ter of time until a new, nonsusceptibie 
pathogenic variant emerges and is 
selected for. 
Goldstein's chief aim now is to ex-
plore patterns of variability in the 
genes that code for adhesin piius 
proteins. Despite the high degree of 
variability his group has discovered, 
he is convinced there is an underlying 
order to the seemingly chaotic chan-
ges affecting those genes. Creating a 
comprehensive picture of the possible 
diversity in piius adhesin structures 
will permit appropriate strategies for 
vaccine development, he said. 
Others involved in the research 
group include Michel Arthur, Ph.D., a 
BUSM National Kidney Foundation fei-
low; Robert Arbeit, M.D., an associate 
professor of medicine; Suzanne Stein-
bach, M.D., an assistant professor of 
pediatrics; Helen Crowe, M.D., an as-
sistant professor of medicine; Lee 
Makowski, Ph.D., a professor of 
physics at Boston University; Craig 
Campanelli, a BUSM student; Roberta 
Dunn, a graduate student in the BUSM 
School of Public Health; and research 
technicians Cheung Kim and Manju 
Agarwal. 
Goldstein's work is supported by 
the National Science Foundation, the 
National Kidney Foundation, the 
Ponds National Suisse pour la Recher-
che Scientifique, the Hood Foundation, 
and the Community Technology Trans-
fer Foundation of Boston University. 
—Riohard P. Anthony 
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